KYLI MYEARS: Open Payments
NPI 1881032795 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,367 in 88 payments from 22 companies in 2025. Trend: 2023 $171 · 2024 $770 · 2025 $2,367
Food & beverage: $2,287Education: $80
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $669 |
| Inspire Medical Systems, Inc. | 3 | $302 |
| Regeneron Healthcare Solutions, Inc. | 12 | $267 |
| GENZYME CORPORATION | 7 | $202 |
| Actelion Pharmaceuticals US, Inc. | 5 | $126 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| Grifols USA, LLC | 3 | $72 |
| Insmed, Inc. | 3 | $71 |
| Viatris Specialty LLC | 4 | $70 |
| Lilly USA, LLC | 3 | $64 |
Products named: DUPIXENT, FASENRA, INSPIRE, UPTRAVI, TEZSPIRE, Prolastin-C Liquid, Arikayce, YUPELRI.
Industry payments across MO — which companies pay providers there.
